Category: Press Releases
2 New mentorship programs via partnership with ICRN/ENS-CCA to support, advise junior researchers in their career choices
Cholangiocarcinoma patients need scientists and researchers to help generate funding for research and treatment of early-stage cholangiocarcinoma, a rare but…
Rare Cancer Day is supported by Cholangiocarcinoma Foundation with video series called ‘Patient Voices’
Foundation offers free care kits to newly diagnosed cholangiocarcinoma patients and caregivers residing in the US SALT LAKE CITY, UTAH…
Rare cancer funding is being raised by Ruth Stage, Inc. to benefit the Cholangiocarcinoma Foundation
Helping to raise funds for a grossly underfunded disease is something you rarely see from a theater company. Yet, that…
Early-stage cancer research funding supported by inaugural virtual auction by Cholangiocarcinoma Foundation
Cholangiocarcinoma patients and scientists need help generating funding for research and treatment of early-stage cholangiocarcinoma, a rare but lethal bile…
New cancer program launched by Cholangiocarcinoma Foundation to connect patients, caregivers with essential resources
The Cholangiocarcinoma Foundation (CCF) is proud to announce the launch of its Newly Diagnosed/New to CCF program to support patients…
Cholangiocarcinoma Foundation CEO named as a finalist in Cancer Community (C2) Awards
SALT LAKE CITY, UT - Cholangiocarcinoma Foundation CEO and Founder Stacie C. Lindsey has been named a finalist of the…
Cholangiocarcinoma Foundation commends FDA approval of new therapy for cholangiocarcinoma patients
SALT LAKE CITY, UT - The Cholangiocarcinoma Foundation (CCF) today applauds the U.S. Food and Drug Administration (FDA) approval of…
Cholangiocarcinoma Foundation raises more than $76,000 in 2nd Annual Moving for the Cure
SALT LAKE CITY, UT - The Cholangiocarcinoma Foundation (CCF) and TeamCCF sponsored its second athletic event, Moving for the Cure.…
Join the Cholangiocarcinoma Foundation's 2nd Annual Moving for the Cure!
Home / Blog / [wpbb post:title] TeamCCF would like to take this opportunity to engage those who want to fundraise…
CCF Celebrates FDA Approval of TRUSELTIQ™ for Cholangiocarcinoma Patients Developed by BridgeBio Pharma Affiliate QED Therapeutics
Home / Blog / [wpbb post:title] On behalf of patients and families impacted by cholangiocarcinoma, the Cholangiocarcinoma Foundation (CCF) celebrates…